The role of global DNA methylation and epigenetic aging in the suicidality of patients with schizophrenia
Schizophrenia Research · 2026-08 · 294 · 192-197
DOI: 10.1016/j.schres.2026.04.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Research, 2026-08. Verfasst von George Nader und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Addiction and Mental Health, Toronto, ON, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Pharmacology & Toxicol…. Hauptthemen laut MEDLINE: DNA Methylation, Schizophrenia, Epigenesis, Genetic, Aging. Die Arbeit nennt 24 Literaturangaben. Gefördert von: American Foundation for Suicide Prevention, Association of Fundraising Professionals, Centre for Addiction and Mental Health Foundation.
Abstract (Originalsprache)
Suicide is a leading cause of death among individuals with schizophrenia. Studies suggest that suicide attempters show increased DNA methylation and shorter telomere lengths, both linked to accelerated biological aging. Recently, DNA methylation has been used to estimate epigenetic aging and telomere length, the former of which serves as the most accurate measure of biological aging. In this study, we investigated whether patients with schizophrenia spectrum disorder (SSD) and a history of suicide attempts show greater biological aging than non-attempters. Epigenetic aging and telomere length were assessed in DNA samples extracted from white blood cells of 60 SSD patients using methylation-based epigenetic clocks. Suicide attempters showed higher epigenetic age acceleration (EAA) on the Hannum DNAm Age clock compared to non-attempters, although other clocks displayed similar trends. However, this was no longer significant after correcting for multiple comparisons (p = 0.0356, pFDR = 0.2136). These findings suggest that accelerated epigenetic aging may be associated with suicide risk in schizophrenia. Finally, investigating the factors underlying this association would improve our understanding of suicidality and the ability to develop effective prevention measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Addiction and Mental Health, Toronto, ON, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada.
- Centre for Addiction and Mental Health, Toronto, ON, Canada.
- Centre for Addiction and Mental Health, Toronto, ON, Canada; University of Toronto, Department of Psychiatry, Toronto, ON, Canada.
- University of Toronto, Department of Psychiatry, Toronto, ON, Canada.
- Centre for Addiction and Mental Health, Toronto, ON, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Pharmacology & Toxicology, Toronto, ON, Canada; University of Toronto, Department of Psychia…
Förderung
- American Foundation for Suicide Prevention
- Association of Fundraising Professionals
- Centre for Addiction and Mental Health Foundation
Zitieren
APA
Nader, G., Raymond, R., Trad, R., Ducharme, M., Graff, A., Gerretsen, P., Fischer, C., & De Luca, V. (2026). The role of global DNA methylation and epigenetic aging in the suicidality of patients with schizophrenia. Schizophrenia Research, 294, 192-197. https://doi.org/10.1016/j.schres.2026.04.020
Vancouver
Nader G, Raymond R, Trad R, Ducharme M, Graff A, Gerretsen P, et al. The role of global DNA methylation and epigenetic aging in the suicidality of patients with schizophrenia. Schizophrenia Research. 2026;294:192-197. doi:10.1016/j.schres.2026.04.020
BibTeX
@article{Nader2026,
author = {Nader, George and Raymond, Roger and Trad, Rawan and Ducharme, Matisse and Graff, Ariel and Gerretsen, Philip and Fischer, Corinne and De Luca, Vincenzo},
title = {The role of global DNA methylation and epigenetic aging in the suicidality of patients with schizophrenia},
journal = {Schizophrenia Research},
year = {2026},
volume = {294},
pages = {192--197},
doi = {10.1016/j.schres.2026.04.020}
}
EUVIMED